SCHEMBL29555526

CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC

nearest known ligand 0.64

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	NPBWR1	P48145	14/20	0.64

▸	OPRD1	P41143	2/20	0.61

▸	CCKAR	P32238	1/20	0.61

▸	CCKBR	P32239	1/20	0.61

▸	GLP1R	P43220	3/20	0.57

▸	OPRM1	P35372	1/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29555471	1.00	NPBWR1 (0.64)	NPBWR1OPRD1CCKARCCKBRGLP1R
SCHEMBL29555481	0.91	GHSR (0.60)	OPRD1CCKARCCKBROPRM1
SCHEMBL29555469	0.90	NPBWR1 (0.66)	NPBWR1
SCHEMBL29556572	0.90	NPBWR1 (0.67)	NPBWR1
SCHEMBL29554941	0.90	NPBWR1 (0.67)	NPBWR1
SCHEMBL26080293	0.89	NPBWR1 (0.67)	NPBWR1OPRD1CCKARCCKBRGLP1R
SCHEMBL29891110	0.88	GLP1R (0.65)	NPBWR1OPRD1CCKARCCKBRGLP1R
SCHEMBL29534976	0.88	GLP1R (0.60)	NPBWR1OPRD1CCKARCCKBRGLP1R
SCHEMBL30518083	0.87	NPBWR1 (0.64)	NPBWR1OPRD1CCKARCCKBR
SCHEMBL26080259	0.86	NPBWR1 (0.65)	NPBWR1OPRD1CCKARCCKBRGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3818070-B1	SYNTHETIC PEPTIDES, PRODRUGS, PHARMACEUTICAL COMPOSITIONS AND USES	BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS (BR)	2026-03-11	—	—	EP	disclosed
CN-112654634-B	Synthetic peptides, prodrugs, pharmaceutical compositions and uses	生物医药产品开发公司	2022-05-27	—	—	CN	disclosed